HAP Trading’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-13,500
Closed -$249K 2398
2021
Q4
$249K Sell
13,500
-1,100
-8% -$97.1K 0.01% 937
2021
Q3
$178K Buy
14,600
+1,400
+11% +$148K 0.01% 1077
2021
Q2
$87K Buy
13,200
+100
+0.8% +$11.9K ﹤0.01% 1266
2021
Q1
$88K Buy
+13,100
New +$1.79M ﹤0.01% 993
2020
Q1
Sell
-1,004,500
Closed -$85K 1297
2019
Q4
$85K Buy
1,004,500
+3,900
+0.4% +$343K ﹤0.01% 586
2019
Q3
$279K Sell
1,000,600
-1,100
-0.1% -$125K 0.02% 430
2019
Q2
$293K Sell
1,001,700
-48,400
-5% -$4.88M 0.02% 436
2019
Q1
$1.35M Buy
1,050,100
+29,600
+3% +$2.52M 0.12% 152
2018
Q4
$4.93M Buy
1,020,500
+21,100
+2% +$1.45M 0.31% 64
2018
Q3
$2.04M Buy
+999,400
New +$65.2M 0.13% 139

Other funds holding EXAS

HAP Trading's EXAS Position: Q1 2023 in Review

HAP Trading sold out of Exact Sciences (EXAS) in Q1 2023, closing a stake of 73,893 shares — an estimated $3.66M sold.

HAP Trading first reported a position in EXAS in Q4 2014 and held it in 7 quarters. The position peaked at $3.66M in Q4 2022. 583 funds tracked by Wall St. Rank hold EXAS as of Q1 2023.

  • HAP Trading reported no remaining Exact Sciences position as of Q1 2023 after selling out during the quarter.
  • HAP Trading sold 73,893 Exact Sciences shares in Q1 2023, an estimated $3.66M.
  • HAP Trading first reported a position in Exact Sciences in Q4 2014 and held it in 7 quarters.
  • HAP Trading's Exact Sciences position peaked at $3.66M in Q4 2022.
  • 583 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2023.

Based on HAP Trading's 13F filing for Q1 2023, filed 12 May 2023.